Regulation of JAK–STAT signalling in the immune system
By K. Shuai, Bin Liu. Nature reviews. Immunology, 2003
1,455 citations recorded by the source corpus.
Subfields: Cancer Research, Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/ca2fd97e57a97ab3165cfbc6bc3de97c6e9f3299
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Immunology
- J. O’Shea
- Y. Kanno
- A. Laurence
- P. Murray
- E. Shevach
- Fang Zhou
- Alexander Y. Rudensky
- Shimon Sakaguchi
In Oncology
Citations in the corpus
- The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells (2017, background): “CIS deficient mice had no impaired function of the immune system [33].”
- Single cell profiling of potentiated phospho-protein networks in cancer cells. (2004, methodology): “…lymphoma cell line U-937 were from pathway maps were drawn based on multiple sources (McCubrey et al., 2000; Rane and Reddy, 2002; Shuai and Liu, 2003; StirewaltAmerican Type Culture Collection (www.atcc.org) and cultured in RPMI medium (Invitrogen, Carlsbad, California) 10% Fetal Calf and…”
- Cytokine signaling modules in inflammatory responses. (2008, background): “With seven members in all (Stat1, Stat2, Stat3, Stat4, Stat5a, Stat5b, and Stat6), these DNA-binding proteins provide a rapid membrane to nucleus mechanism for regulation of gene expression (Shuai and Liu, 2003).”
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation (2009, background): “Moreover, protein tyrosine phosphatases (PTPs) shp1 and shp-2 can also lead to the dephosphorylation of receptors and JAKs then inhibit IFN-γ signaling [45].”
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550) (2011, background): “Activated STATs dimerize, translocate to the nucleus, and regulate the expression of numerous genes (4).”
- Nonredundant roles for Stat5a/b in directly regulating Foxp3. (2007, methodology): “We therefore approached this problem in two ways: (1) stem cell transplantation using Stat5 / precursors; and (2) tissue-specific deletion of Stat5 using transgenic expression of Cre.”